Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer - a phase II study.

Author： Allen M.   Vaughan M.   Webb A.   Johnston S.   Savage P.   Eisen T.   Bates S.   Morre J.   Ahern R.   Gore M.  

Publisher： Elsevier

ISSN： 1078-1439

Source： Urologic Oncology: Seminars and Original Investigations, Vol.7, Iss.2, 2002-03, pp. : 83-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II trial of interleukin 2, interferon , and 5-fluorouracil in metastatic renal cell cancer - a cytokine working group study.

By Dutcher J.   Logan T.   Gordon M.   Sosman J.   Weiss G.   Margolin K.   Plasse T.   Mier J.   Lotze M.   Clark J.   Atkins M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 83-84

Elsevier

Access to resources Recommend Favorite

A Phase II Study of Continuous Infusional 5-Fluorouracil (5-FU) and Subcutaneous Interleukin-2 (IL-2) in Metastatic Renal Cancer

By Savage P.   Costelna D.   Moore J.   Gore M.E.  

European Journal of Cancer, Vol. 33, Iss. 7, 1997-06 ,pp. : 1149-1151

Elsevier

Access to resources Recommend Favorite

Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil.

By Negrier S.   Caty A.   Lesimple T.   J-Y D.   Escudier B.   J-F R.   Viens P.   Gomez F.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 84-84

Elsevier

Access to resources Recommend Favorite

A phase I study of the trinuclear platinum compound, BBR 3464, in combination with protracted venous infusional 5-fluorouracil in patients with advanced cancer

By Gourley Charlie   Cassidy James   Edwards Chris   Samuel Leslie   Bisset Donald   Camboni Gabriella   Young Anne   Boyle Dorothy   Jodrell Duncan  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 2, 2004-02 ,pp. : 95-101

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of irinotecan by 24-h intravenous infusion in combination with 5-fluorouracil in metastatic colorectal cancer

By Kambe Mariko   Kikuchi Hiroaki   Gamo Makio   Yoshioka Takashi   Ohashi Yasuo   Kanamaru Ryunosuke  

International Journal of Clinical Oncology, Vol. 17, Iss. 2, 2012-04 ,pp. : 150-154

Springer Publishing Company

Access to resources Recommend Favorite